|
It was reported that during a clinical trial (b)(4) lower gastrointestinal procedure the patient experienced a pelvic haematoma.The patient required diagnostic imaging - ct angio, drug therapy, and a blood transfusion.They also required in-patient hospitalization or prolongation of existing hospitalization.The adverse event has a possible relationship with both the device and study procedure.
|
|
(b)(4).Date sent: 7/31/2025.D4 batch #: unknown.Attempts are being made to obtain the following information.To date, no response has been provided.If further details are received at a later date, a supplemental medwatch will be sent: were there any device issues identified during operation? if yes, please describe how was the device used in the procedure? what vessel was the device used on? was there a re-operation? was the bleeding source identified? and was it where the device was used? did the patient have any chemotherapy prior to the procedure? did the patient have any clotting issues? an analysis of the product could not be performed since a physical sample was not received for evaluation.A manufacturing record evaluation was performed for the finished device lot number, and no non-conformance were identified.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
(b)(4).Date sent: 9/10/2025.Additional information was requested and the following was obtained: were there any device issues identified during operation? if yes, please describe.Confirmed no device issues during procedure.How was the device used in the procedure? unsure what other information you need here ¿ device was used as per manufacturer¿s instructions and training we received.I have been using the harmonic in some form or another for >10 years and i have not changed my practice.What vessel was the device used on? inferior mesenteric artery, inferior mesenteric vein confirmed.Was there a re-operation? still no further re-intervention.Was the bleeding source identified? and was it where the device was used? scans post-op show a renal bed large haematoma next to her psoas muscle excision but the bleeding vessel was not identified.Did the patient have any chemotherapy prior to the procedure? no chemotherapy or any oncological treatment within 30 days of procedure.Did the patient have any clotting issues? ¿ i could not see any pre-existing anti-coagulation for this participant.
|